SCOPUS 정보 검색 플랫폼

Endocrine

Volumn 46, Issue 1, 2014, Pages 3-5

SMART diabetes: The way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes)

(2) Maddaloni, Ernesto a Pozzilli, Paolo a,b,c,d

a UNIVERSITY CAMPUS BIO MEDICO (Italy)

b Centre for Diabetes (United Kingdom)

c London School of Medicine (United Kingdom)

d UNIVERSITY OF LONDON (United Kingdom)

Author keywords

Diabetes; Multifactorial Approach; Personalized therapy; Safety

Indexed keywords

FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN;

CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DRUG SAFETY; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREATITIS; PATIENT SAFETY; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INDIVIDUALIZED MEDICINE; PATIENT SAFETY; RISK;

EID: 84898807885 PISSN: 1355008X EISSN: 15590100 Source Type: Journal
DOI: 10.1007/s12020-013-0128-3 Document Type: Review

Times cited : (21)

References (10)

1
- 65649106228
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials
- K.K. Ray, S.R. Seshasai, S. Wijesuriya, R. Sivakumaran, S. Nethercott, D. Preiss, S. Erqou, N. Sattar, Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373, 1756-1772 (2009)
- (2009) Lancet , vol.373 , pp. 1756-1772
- Ray, K.K.¹ Seshasai, S.R.² Wijesuriya, S.³ Sivakumaran, R.⁴ Nethercott, S.⁵ Preiss, D.⁶ Erqou, S.⁷ Sattar, N.⁸

2
- 77952778197
- The A1C and ABCD of glycaemia management in type 2 diabetes: A physician's personalized approach
- P. Pozzilli, R.D. Leslie, J. Chan, R. De Fronzo, L. Monnier, I. Raz, S. Del Prato, The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes/Metab. Res. Rev. 26, 239-244 (2010)
- (2010) Diabetes/Metab. Res. Rev. , vol.26 , pp. 239-244
- Pozzilli, P.¹ Leslie, R.D.² Chan, J.³ De Fronzo, R.⁴ Monnier, L.⁵ Raz, I.⁶ Del Prato, S.⁷

3
- 84866268783
- American diabetes association (ADA); european association for the study of diabetes (EASD). Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American diabetes association (ADA) and the european association for the study of diabetes (EASD)
- S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Fer-rannini, M. Nauck, A.L. Peters, A. Tsapas, R. Wender, D.R. Matthews, American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35, 1364-1379 (2012)
- (2012) Diabetes Care , vol.35 , pp. 1364-1379
- Inzucchi, S.E.¹ Bergenstal, R.M.² Buse, J.B.³ Diamant, M.⁴ Ferrannini, E.⁵ Nauck, M.⁶ Peters, A.L.⁷ Tsapas, A.⁸ Wender, R.⁹ Matthews, D.R.¹⁰

4
- 84881189911
- Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): A 24 week, randomised, double-blind, placebo-controlled study
- W.D. Strain, V. Lukashevich, W. Kothny, MJ. Hoellinger, M.P. Paldánius, Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 382, 409-416 (2013)
- (2013) Lancet , vol.382 , pp. 409-416
- Strain, W.D.¹ Lukashevich, V.² Kothny, W.³ Hoellinger, M.J.⁴ Paldánius, M.P.⁵

5
- 84878185729
- A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?
- P.C. Butler, M. Elashoff, R. Elashoff, E.A. Gale, A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 36, 2118-2125 (2013)
- (2013) Diabetes Care , vol.36 , pp. 2118-2125
- Butler, P.C.¹ Elashoff, M.² Elashoff, R.³ Gale, E.A.⁴

6
- 77957742069
- Severe hypoglycemia and risks of vascular events and death
- S. Zoungas, A. Patel, J. Chalmers, B.E. de Galan, Q. Li, L. Billot, M. Woodward, T. Ninomiya, B. Neal, S. MacMahon, D.E. Grobbee, A.P. Kengne, M. Marre, S. Heller, Severe hypoglycemia and risks of vascular events and death. N. Engl. J. Med. 363, 1410-1418 (2010)
- (2010) N. Engl. J. Med. , vol.363 , pp. 1410-1418
- Zoungas, S.¹ Patel, A.² Chalmers, J.³ De Galan, B.E.⁴ Li, Q.⁵ Billot, L.⁶ Woodward, M.⁷ Ninomiya, T.⁸ Neal, B.⁹ MacMahon, S.¹⁰ Grobbee, D.E.¹¹ Kengne, A.P.¹² Marre, M.¹³ Heller, S.¹⁴

7
- 84864861863
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the jupiter trial
- P.M. Ridker, A. Pradhan, J.G MacFadyen, P. Libby, R.J. Glynn, Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the Jupiter trial. Lancet 380, 565-571 (2012)
- (2012) Lancet , vol.380 , pp. 565-571
- Ridker, P.M.¹ Pradhan, A.² MacFadyen, J.G.³ Libby, P.⁴ Glynn, R.J.⁵

8
- 84877152350
- Medication prescribing in frail older people
- R.E. Hubbard, M.S. O'Mahony, K.W. Woodhouse, Medication prescribing in frail older people. Eur. J. Clin. Pharmacol. 69, 319-326 (2013)
- (2013) Eur. J. Clin. Pharmacol. , vol.69 , pp. 319-326
- Hubbard, R.E.¹ O'Mahony, M.S.² Woodhouse, K.W.³

9
- 84864270406
- Basal insulin and cardiovascular and other outcomes in dysglycemia
- H.C. Gerstein, J. Bosch, GR. Dagenais, R. Díaz, H. Jung, A.P. Maggioni, J. Pogue, J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Rydén, S. Yusuf, Basal insulin and cardiovascular and other outcomes in dysglycemia. N. Engl. J. Med. 367, 319-328 (2012)
- (2012) N. Engl. J. Med. , vol.367 , pp. 319-328
- Gerstein, H.C.¹ Bosch, J.² Dagenais, G.R.³ Díaz, R.⁴ Jung, H.⁵ Maggioni, A.P.⁶ Pogue, J.⁷ Probstfield, J.⁸ Ramachandran, A.⁹ Riddle, M.C.¹⁰ Rydén, L.E.¹¹ Yusuf, S.¹²

10
- 84885997413
- ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- doi:10.1093/eurheartj/eht108
- L. Rydén, P. Grant, S.D. Anker, C. Berne, F. Consentino, N. Danchin, C. Deaton, J. Escaned, H.P. Hammes, H. Huikuri, M. Marre, N. Marx, L. Mellbin, J. Ostergren, J. Ostergren, C. Patrono, P. Seferovic, Uva, Taskinen, M. Tendera, J. Tuomilehto, P. Valensi, JL. Zamorano, ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. (2013). doi:10.1093/eurheartj/eht108
- (2013) Eur. Heart J.
- Rydén, L.¹ Grant, P.² Anker, S.D.³ Berne, C.⁴ Consentino, F.⁵ Danchin, N.⁶ Deaton, C.⁷ Escaned, J.⁸ Hammes, H.P.⁹ Huikuri, H.¹⁰ Marre, M.¹¹ Marx, N.¹² Mellbin, L.¹³ Ostergren, J.¹⁴ Ostergren, J.¹⁵ Patrono, C.¹⁶ Seferovic, P.¹⁷ Uva, T.¹⁸ Tendera, M.¹⁹ Tuomilehto, J.²⁰ Valensi, P.²¹ Zamorano, J.L.²² more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.